KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Tax Provisions (2016 - 2025)

Eli Lilly's Tax Provisions history spans 17 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Tax Provisions rose 159.11% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $5.1 billion, up 143.59%, while the annual FY2025 figure was $5.1 billion, 143.59% up from the prior year.
  • Tax Provisions reached $1.6 billion in Q4 2025 per LLY's latest filing, down from $1.6 billion in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.6 billion in Q3 2025 to a low of $113.8 million in Q4 2021.
  • Average Tax Provisions over 5 years is $481.5 million, with a median of $306.0 million recorded in 2023.
  • Peak YoY movement for Tax Provisions: plummeted 67.7% in 2021, then skyrocketed 325.83% in 2023.
  • A 5-year view of Tax Provisions shows it stood at $113.8 million in 2021, then soared by 39.46% to $158.7 million in 2022, then surged by 100.95% to $318.9 million in 2023, then skyrocketed by 97.08% to $628.5 million in 2024, then soared by 159.11% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Tax Provisions are $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.1 billion (Q2 2025).